RNXT vs USB · rev $266.0K vs P/E 12, rev $28.66B
RenovoRx Inc (RNXT) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
RNXT currently screens at market cap $47.0M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the RNXT and USB stock pages for the full models.
Not investment advice.